Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineinduced mouse model of Parkinson's disease

Neurological Research

Volumn 32, Issue SUPPL.1, 2010, Pages

  Doo, Ah Reum ^a   Kim, Seung Tae ^a,b   Kim, Seung Nam ^a   Moon, Woongjun ^a   Yin, Chang Shik ^a   Chae, Younbyoung ^a   Park, Hun Kuk ^c   Lee, Hyejung ^a   Park, Hi Joon ^a  

^a Kyung Hee University   (South Korea)

^b Pusan National University   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

Author keywords

1 methyl 4 phenyl 1; 2; 3; 6 tetrahydropyridine; Bee venom; Parkinson's disease; Pharmaceutical acupuncture; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BEE VENOM; STRESS ACTIVATED PROTEIN KINASE; TYROSINE 3 MONOOXYGENASE;

ACUPUNCTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOREACTIVITY; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ACUPUNCTURE THERAPY; ACUTE DISEASE; ANIMALS; BEE VENOMS; CELL DEATH; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICE; MICE, INBRED C57BL; NEURONS; NEUROPROTECTIVE AGENTS; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PHOSPHORYLATION; SUBSTANTIA NIGRA; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 77949438101     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164109x12537002794282     Document Type: Article

References (21)

1. Oertel WH, Ellgring H. Parkinson's disease-medical education and psychosocial aspects. Patient Educ Couns 1995; 26: 71-79
2. Tanner CM. Is the cause of Parkinson's disease environmental or hereditary? Evidence from twin studies. Adv Neurol 2003; 91: 133-142
3. Mizuno Y, Hattori N, Kitada T, et al. Familial Parkinson's disease. Alpha-synuclein and parkin. Adv Neurol 2001; 86: 13-21
4. Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol 2005; 76: 77-98
5. Son DJ, Lee JW, Lee YH, et al. Therapeutic application of antiarthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther 2007; 115: 246-270
6. Nam KW, Je KH, Lee JH, et al. Inhibition of COX-2 activity and proinflammatory cytokines (TNF-alpha and IL-1beta) production by water-soluble sub-fractionated parts from bee (Apis mellifera) venom. Arch Pharm Res 2003; 26: 383-388
7. Kim HW, Kwon YB, Ham TW, et al. Acupoint stimulation using bee venom attenuates formalin-induced pain behavior and spinal cord fos expression in rats. J Vet Med Sci 2003; 65: 349-355
8. Orsolić N, Sver L, Verstovsdk S, et al. Inhibition of mammary carcinoma cell proliferation in vitro and tumor growth in vivo by bee venom. Toxicon 2003; 41: 861-870
9. Choi SH, Cho SK, Kang SS, et al. Effect of apitherapy in piglets with preweaning diarrhea. Am J Chin Med 2003; 31: 321-326
10. Song JY, Song HS. The effect of bee venom on scopolamine induced memorial impairment. J Kor Acu Mox Soc 2006; 23: 103-115
11. Nicotraa A, Parvezb S. Apoptotic molecules and MPTP-induced cell death. Neurotoxicol Teratol 2002; 24: 599-605
12. Luo Y, Umegaki H, Wang X, et al. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 1998; 273: 3756-3764
13. Wang W, Shiab L, Xie Y, et al. SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease. Neurosci Res 2004; 48: 195-202
14. Saporito MS, Brown EM, Miller MS, et al. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1- methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J Pharmacol Exp Ther 1999; 288: 421-427
15. Jeon S, Kim YJ, Kim ST, et al. Proteomic analysis of the neuroprotective mechanisms of acupuncture treatment in a Parkinson's disease mouse model. Proteomics 2008; 8: 4822-4832
16. Park HJ, Lim S, Joo WS, et al. Acupuncture prevents 6- hydroxydopamine-induced neuronal death in the nigrostriatal dopaminergic system in the rat Parkinson's disease model. Exp Neurol 2003; 1: 93-98
17. Hunot S, Vila M, Teismann P, et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA 2004; 101: 665-670
18. Kwon YB, Kim JH, Yoon JH, et al. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: A comparative study with needle acupuncture. Am J Chin Med 2001; 29: 187-199
19. Lee JD, Park HJ, Chae Y, et al. An overview of bee venom acupuncture in the treatment of arthritis. Evid Based Complement Alternat Med 2005; 2: 79-84
20. Boyd JD, Jang H, Shepherd KR, et al. Response to MPTP (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Brain Res 2007; 1175: 107-116
21. He XJ, Yamauchi H, Uetsuka K, et al. Neurotoxicity of MPTP to migrating neuroblasts: Studies in acute and subacute mouse models of Parkinson's disease. Neurotoxicology 2008; 29: 413-420